Conference Call with Sumitomo Chemical India Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.
Agrochemicals company Sumitomo Chemical India announced Q3FY25 results Financial Highlights: Revenue from Operations: Rs 641.9 crore in Q3FY25 (+18% YoY, -35% QoQ); Rs 2,469.1 crore in 9MFY25 (+14% YoY). EBITDA: Rs 106.1 crore in Q3FY25 (+61% YoY, -57% QoQ); Rs 512.5 crore in 9MFY25 (+53% YoY). EBITDA Margin: 16.5% in Q3FY25 (up 439 bps YoY, down 829 bps QoQ); 20.8% in 9MFY25 (up 534 bps YoY). Profit Before Tax (PBT): Rs 116.5 crore in Q3FY25 (+55% YoY, -55% QoQ); Rs 547.1 crore in 9MFY25 (+54% YoY). PBT Margin: 18.1% in Q3FY25 (up 425 bps YoY, down 812 bps QoQ); 22.2% in 9MFY25 (up 584 bps YoY). Profit After Tax (PAT): Rs 87.4 crore in Q3FY25 (+60% YoY, -55% QoQ); Rs 406.7 crore in 9MFY25 (+56% YoY). PAT Margin: 13.6% in Q3FY25 (up 352 bps YoY, down 586 bps QoQ); 16.5% in 9MFY25 (up 449 bps YoY). Business Highlights: Despite the challenging environment, we delivered resilient performance in Q3FY25, with net revenue from operations increasing by 18% YoY. This growth was primarily driven by strong volume performance in both domestic and export markets underscored by our strategic focus on demand generation. Export revenues grew by 38% YoY, with Latin America being a standout performer. Europe also posted strong growth. Gross margin improved to 42.1% from 39.8% in Q3FY24, supported by company’s focus on high-margin products - offsetting the pricing pressure in traditional product categories. Herbicides recorded robust volume growth - though it showcased slightly lower growth in monetary terms due to pricing pressures as compared to last year. Fungicides growth rebounded on account of lower base, due to temporary shutdown of fungicide plant last year.. We continue to monitor the progress of the ongoing Rabi season which has commenced with higher sowing acreage for wheat, rice, corn, and pulses compared to the previous year. The full impact of the Rabi season is expected to be reflected in Q4FY25. Result PDF